BioLife Solutions Inc (BLFS) — Capital Reinvestment Ratio

Latest as of December 2025: 2.95x

BioLife Solutions Inc (BLFS) has a Capital Reinvestment Ratio of 2.95x as of December 2025, meaning it reinvests 3% of its operating cash flow ($4.92 Million) in capital expenditures ($14.48 Million). See BioLife Solutions Inc (BLFS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.95x
Capex / Operating Cash Flow

Operating Cash Flow

$4.92 Million
USD

Capital Expenditures

$14.48 Million
USD

Data as of

Dec 2025
Most recent filing

BioLife Solutions Inc Capital Reinvestment Ratio (1998–2025)

This chart tracks BioLife Solutions Inc's Capital Reinvestment Ratio across 10 annual periods.

Annual Capital Reinvestment Ratio for BioLife Solutions Inc (1998–2025)

Year-by-year Capital Reinvestment Ratio for BioLife Solutions Inc from 1998 to 2025. For live market cap and broader valuation context, see BioLife Solutions Inc market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.47x $20.11 Million $9.48 Million ▲ +23.1%
2024 0.38x $8.43 Million $3.23 Million ▼ -46.2%
2020 0.71x $6.51 Million $4.63 Million ▲ +27.8%
2019 0.56x $1.21 Million $675.00K ▲ +161.3%
2018 0.21x $2.35 Million $500.00K ▼ -10.4%
2017 0.24x $605.00K $143.77K ▼ -85.3%
2013 1.62x $146.01K $236.67K ▲ +20.3%
2012 1.35x $854.93K $1.15 Million ▲ +954.6%
2004 0.13x $515.10K $65.80K ▼ -98.5%
1998 8.57x $29.12K $249.62K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow